UCLA study assesses cost-effectiveness of Hepatitis B drugs
Researchers at UCLA and the Veterans Affairs Greater Los Angeles Healthcare System conducted the largest and most comprehensive study in comparing the cost-effectiveness of current modern drugs for treating hepatitis B -- a disease affecting 350 million worldwide. Published in the May 17 Annals of Internal Medicine, the study may help physicians worldwide in making treatment decisions. Re...Gene signature assesses breast cancer outcomes
A test that looks at the expression of 70 genes linked to breast cancer can accurately assess a patient's risk of recurrence or death, according to an article in the September 6 issue of the Journal of the National Cancer Institute. In previous research, scientists at the Netherlands Cancer Institute in Amsterdam identified 231 genes associated with patient outcomes in a group of patients...New Approach Assesses Risk of Water-Borne Pathogen Disease
Researchers at the University of California, San Diego (UCSD) School of Medicine, along with colleagues at the University Peruana Cayetano Heredia in Lima, Peru, have// developed a novel approach for assessing the risk to humans of acquiring leptospirosis – a severe, water-borne disease that is the common cause of severe jaundice, renal failure and lung hemorrhage in urban areas throughou...IMRT Versus 3D CRT For Prostate Cancer, New Long-Term Data Assesses Side Effects
New research findings show men have fewer long-term gastrointestinal side effects with intensity-modulated radiation therapy (IMRT) than with three-dimensional// conformal radiation therapy (3D CRT) for prostate cancer treatment, despite the higher doses of radiation used in the IMRT group. These and other data, including long-term genitourinary side effects, were presented today at the 4...